TTC9 Antikörper (AA 1-217) (APC)
Kurzübersicht für TTC9 Antikörper (AA 1-217) (APC) (ABIN8046012)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-217
-
Verwendungszweck
- Anti-TTC9 Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human TTC9 recombinant protein (Position: M1-R217).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- TTC9 (Tetratricopeptide Repeat Domain 9 (TTC9))
-
Andere Bezeichnung
- TTC9
-
Hintergrund
-
Background: This gene encodes a protein that contains three tetratricopeptide repeats. The gene has been shown to be hormonally regulated in breast cancer cells and may play a role in cancer cell invasion and metastasis.
Gene Full Name: tetratricopeptide repeat domain 9
-
Gen-ID
- 23508
-
UniProt
- Q92623
Target
-